SWOG S1613

Primary Category:

Treatment Protocols

Disease Category:

Colon, Colon Metastatic, Gastrointestinal, Rectal, Rectal Metastatic


Temporarily Closed

A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (MCRC) with HER-2 Amplification



Effective immediately, May 17th, 2019, S1613 Step 1, is temporarily closed to accrual of new patients to accommodate the relocation of the screening laboratory. Patients may continue to be registered to Step 2.